Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/76956
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bartlewski, Pawel Mieczyslaw | en_US |
dc.contributor.author | Aravindakshan, J. | en_US |
dc.contributor.author | Beard, Andrew P. | en_US |
dc.contributor.author | Nelson, M. L. | en_US |
dc.contributor.author | Batista Arteaga, Miguel | en_US |
dc.contributor.author | Cook, Susan J. | en_US |
dc.contributor.author | Rawlings, N. C. | en_US |
dc.date.accessioned | 2020-12-23T10:53:36Z | - |
dc.date.available | 2020-12-23T10:53:36Z | - |
dc.date.issued | 2001 | en_US |
dc.identifier.issn | 0006-3363 | en_US |
dc.identifier.other | WoS | - |
dc.identifier.uri | http://hdl.handle.net/10553/76956 | - |
dc.description.abstract | When ovulation is induced with gonadotrophin-releasing hormone (GnRH) in anoestrous ewes, a proportion of animals fail to form normal (full-lifespan) corpora lutea (CL). Progesterone treatment before GnRH prevents luteal inadequacy. It remains uncertain whether a similar effect, achieved with medroxyprogesterone acetate (MAP) from intravaginal sponges, is mediated by influences on growing ovarian follicles and/or secretion of gonadotrophic hormones, before and after GnRH treatment. Two experiments were performed, on 13 and 11 anoestrous Western white-faced ewes, respectively. Seven and six ewes, respectively, received MAP-containing sponges (60 mg) for 14 days; the remaining ewes served as untreated controls. To test the effect of timing of GnRH administration after pre-treatment with MAP-releasing sponges, GnRH injections (250 ng every 2 h for 24 h followed by a bolus injection of 125 μg of GnRH i.v.) were given either immediately (Experiment 1) or 24 h after sponge removal in the treated ewes (Experiment 2). Ovarian follicular dynamics (follicles reaching ≥5 mm in size) and development of luteal structures were monitored using transrectal ultrasonography. In Experiment 1, the mean ovulation rate (0.7±0.3 and 1.0±0.4) and proportion of ovulating ewes (57 and 67%, respectively) did not vary (P>0.05) between MAP-treated and control ewes. Normal (full-lifespan) CL were detected in 29% of treated and 67% of control ewes (P>0.05). In Experiment 2, the mean ovulation rate (2.3±0.2 and 1.2±0.6; P<0.05) and percentage of ewes with normal (full-lifespan) CL (100 and 40%, respectively; P<0.10) were greater in the treated compared to control ewes. In Experiment 1, the mean peak concentration of the GnRH-induced LH surge was lower (P<0.05) in MAP-treated than in control ewes. There were no significant differences between MAP-treated and control ewes in the characteristics of follicular waves, mean daily serum FSH concentrations, and secretory parameters of LH/FSH, based on intensive blood sampling conducted 1 day before sponging and 1 day before sponge removal. It is concluded that treatment with MAP has no effect on the tonic secretion of LH/FSH or follicular wave development in anoestrous ewes. However, the GnRH-stimulated LH discharge was attenuated in the ewes that received MAP-impregnated sponges for 14 days and were treated with GnRH immediately after sponge withdrawal. Ovulatory response and CL formation were increased when GnRH was administered 24 h after sponge removal. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Biology of reproduction | en_US |
dc.source | Biology of reproduction [ISSN 0006-3363], v. 64 (sup. 1), p. 150, (2001) | en_US |
dc.subject | 310907 Patología | en_US |
dc.subject.other | Medroxyprogesterone acetate | en_US |
dc.subject.other | Gonadotrophin-releasing hormone | en_US |
dc.subject.other | Ovulation | en_US |
dc.subject.other | Anoestrus | en_US |
dc.subject.other | Ewe | en_US |
dc.title | Effects of medroxyprogesterone acetate (MAP) on ovarian antral follicle development, gonadotropin secretion and response to GnRH in seasonally anovular ewes | en_US |
dc.type | info:eu-repo/semantics/conferenceObject | en_US |
dc.type | ConferenceObject | en_US |
dc.identifier.isi | 000169570900167 | - |
dc.description.lastpage | 150 | en_US |
dc.description.firstpage | 150 | en_US |
dc.relation.volume | 64 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Actas de congresos | en_US |
dc.contributor.daisngid | 329584 | - |
dc.contributor.daisngid | 1885802 | - |
dc.contributor.daisngid | 508118 | - |
dc.contributor.daisngid | 28347052 | - |
dc.contributor.daisngid | 3336300 | - |
dc.contributor.daisngid | 101614 | - |
dc.contributor.daisngid | 133303 | - |
dc.description.numberofpages | 1 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Bartlewski, PM | - |
dc.contributor.wosstandard | WOS:Aravindakshan, J | - |
dc.contributor.wosstandard | WOS:Beard, AP | - |
dc.contributor.wosstandard | WOS:Nelson, ML | - |
dc.contributor.wosstandard | WOS:Batista-Arteaga, M | - |
dc.contributor.wosstandard | WOS:Cook, SJ | - |
dc.contributor.wosstandard | WOS:Rawlings, NC | - |
dc.date.coverdate | 2001 | en_US |
dc.identifier.supplement | 1 | - |
dc.identifier.ulpgc | Sí | en_US |
dc.description.jcr | 3,508 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Medicina Veterinaria e Investigación Terapéutica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Patología Animal, Producción Animal, Bromatología y Tecnología de Los Alimentos | - |
crisitem.author.orcid | 0000-0001-9753-4786 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Batista Arteaga, Miguel | - |
Appears in Collections: | Actas de congresos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.